Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ERNA Eterna Therapeutics > Detailed Quotes

ERNA Eterna Therapeutics

Watchlist
4.760
+0.110+2.37%
Close  02/03 16:00 ET
4.7600.0000.00%
Post Mkt Price 02/03 17:54 ET
High
4.866
Open
4.550
Turnover
80.54K
Low
4.550
Pre Close
4.650
Volume
16.84K
Market Cap
24.40M
P/E(TTM)
Loss
52wk High
51.400
Shares
5.13M
P/E(Static)
Loss
52wk Low
2.735
Float Cap
15.66M
Bid/Ask %
-66.67%
Historical High
1613.400
Shs Float
3.29M
Volume Ratio
1.02
Historical Low
2.735
Dividend TTM
--
Div Yield TTM
--
P/B
2.77
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.51%
Amplitude
6.79%
Avg Price
4.783
Lot Size
1
Float Cap
15.66M
Bid/Ask %
-66.67%
Historical High
1613.400
Shs Float
3.29M
Volume Ratio
1.02
Historical Low
2.735
Dividend TTM
--
P/B
2.77
Dividend LFY
--
Turnover Ratio
0.51%
Amplitude
6.79%
Avg Price
4.783
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Eterna Therapeutics Inc.(formerly Brooklyn ImmunoTherapeutics, Inc. ) is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.
CEO: Dr. Matthew Angel
Market: NASDAQ
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist